Clinical Trial Update: Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fasting Condition [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study of Levocetirizine Dihydrochloride 5 mg tablets completed under fasting conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Idiopathic Urticaria

Drugs mentioned

• Levocetirizine Dihydrochloride Tablets 5 mg (levocetirizine dihydrochloride)

Snippet

Sponsor: IPCA Laboratories Ltd. | Conditions: Fasting State | Phase 1 | Status: COMPLETED